[1] Siegel R L, Miller K D, Jemal A. Cancer statistics, 2017[J]. CA:A Cancer Journal for Clinicians, 2017,67(1):7-30.
[2] Shetty M K. Screening for breast cancer with mammography:current status and an overview[J]. Indian Indian Journal of Surgical Oncology, 2010,1(3):218-223.
[3] Mori M, Akashi-Tanaka S, Suzuki S, et al.Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts[J]. Breast Cancer, 2017,24(1):104-110.
[4] D'Orsi C J, Sickles E A, Mendelson E B, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System[M]. Reston, VA:American College of Radiology, 2013.
[5] Marmot M G, Altman D G, Cameron D A, et al. The benefits and harms of breast cancer screening:an independent review[J]. British Journal of Cancer, 2013,108(11):2205-2240.
[6] Francescone M A, Jochelson M S, Dershaw D D, et al. Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM)[J]. European Journal of Radiology, 2014,83(8):1350-1355.
[7] Bhimani C, Li L, Liao L, et al. Contrast-enhanced spectral mammography:modality-specific artifacts and other factors which may interfere with image quality[J]. Academic Radio-logy, 2017,24(1):89-94.
[8] 姜婷婷,张盛箭,李瑞敏,等.对比增强能谱X线摄影对乳腺疾病的诊断价值[J]. 中华放射学杂志, 2017, 51(4):273-278. Jiang T T, Zhang S J, Li R M, et al. Diagnostic performance of contrast-enhanced spectral mammography[J].Chinese Journal of Radiology, 2017,51(4):273-278.
[9] Lobbes M B, Lalji U, Houwers J, et al. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme[J]. European Radiology, 2014,24(7):1668-1676.
[10] Fallenberg E M, Dromain C, Diekmann F, et al. Contrast-enhanced spectral mammography versus MRI:initial results in the detection of breastcancer and assessment of tumour size[J]. European Radiology, 2014,24(1):256-264.
[11] Iotti V, Ravaioli S, Vacondio R, et al. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring:a comparison with breast magnetic resonance imaging[J]. Breast Cancer Research, 2017,19(1):106.
[12] Barra F R, de Souza F F, Camelo REFA, et al. Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer:a feasibility study[J]. Radiologia Brasileira, 2017,50(4):224-230.
[13] Cheung Y C, Lin Y C, Wan Y L, et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone:interobserver blind-reading analysis[J]. European Radiology, 2014,24(10):2394-2403.
[14] Houben I P L, Van de Voorde P, Jeukens C R L P N, et al. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits[J]. European Journal of Radiology, 2017,94:31-37.
[15] Badr S, Laurent N, Régis C, et al. Dual-energy contrast-enhanced digital mammography in routine clinical practice in 2013[J]. Diagnostic Interventional Imaging, 2014,95(3):245-258.
[16] 俞敏秋, 李俊晨. 对比增强能谱成像与动态增强磁共振成像诊断乳腺癌的对比研究[J]. 中国医疗设备, 2017,32(11):74-77. YU M Q, LI J C. Comparative study of contrast-enhanced spectral mammography and dynamic contrast-enhanced magnetic resonance imaging in diagnosis of breast cancer[J]. China Medical Devices, 2017,32(11):74-77.
[17] Patel B K, Hilal T, Covington M, et al. Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy[J]. Annals of Surgical Oncology, 2018,25(5):1350-1356.
[18] Sogani J, Morris E A, Kaplan J B, et al. Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging[J]. Radiology, 2017,282(1):63-73.
[19] Patel B K, Lobbes M B I, Lewin J, et al. Contrast enhanced spectral mammography:a review[J]. Semin Ultrasound CT MR, 2018,39(1):70-79. |